The expression of Sox2 in prostate cancer cells, however, does not result in changes in differentiation-specific PSA expression, an increase in CD133-positive putative cancer stem/initiating cells, or the expression of known human Embryonic Stem Cells (hESC)-associated Sox2 target genes. Here, KLK3 is linked to Familial prostate cancer.